Article
A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow
2025-11-27
Abstract excerpt
In cancer patients, circulating cell-free DNA (cfDNA) is released into body fluids from both healthy and cancer cells. The proportion of tumor-derived cfDNA serves as a surrogate marker of tumor burden allowing disease monitoring. Tumoral cfDNA can be distinguished based on patient specific tumoral mutations or using more general tumor specific DNA methylation patterns, that are preserved on tumoral cfDNA. DNAm pr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b9edab66-abf7-590f-9bcd-b4835a04d73f
- DOI
- 10.1101/2025.11.27.688590
